Long-term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9

Authors

Calvin J. Stephens, Washington University School of Medicine in St. Louis
Elvin J. Lauron, Washington University School of Medicine in St. Louis
Elena Kashentseva, Washington University School of Medicine in St. Louis
Zhi Hong Lu, Washington University School of Medicine in St. Louis
Wayne M. Yokoyama, Washington University School of Medicine in St. Louis
David T. Curiel, Washington University School of Medicine in St. Louis

Journal

Journal of Controlled Release

Publication Date

2019

Volume

298

Inclusive Pages

128-141

Document Type

Open Access Publication

DOI

10.1016/j.jconrel.2019.02.009

Rights and Permissions

Stephens CJ, Lauron EJ, Kashentseva E, Lu ZH, Yokoyama WM, Curiel DT (2019) Long-term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9. Journal of Controlled Release, 298:128-141. https://doi.org/10.1016/j.jconrel.2019.02.009 © 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/)

Recommended Citation

Stephens, Calvin J.; Lauron, Elvin J.; Kashentseva, Elena; Lu, Zhi Hong; Yokoyama, Wayne M.; and Curiel, David T., "Long-term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9." Journal of Controlled Release. 298, 128-141. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/7738